Dr. Paul Meyers, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Sarcoma
Studies Ewing Sarcoma
3 reported clinical trials
6 drugs studied
Affiliated Hospitals
More about Paul Meyers, MD
Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Paul Meyers, MD has experience with
- Irinotecan
- Temozolomide
- Seclidemstat
- Cyclophosphamide
- Topotecan
- L-MTP-PE
Breakdown of trials Paul Meyers, MD has run
Ewing Sarcoma
Soft Tissue Sarcoma
Histiocytoma
Fibrosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Meyers, MD specialize in?
Paul Meyers, MD focuses on Sarcoma and Ewing Sarcoma. In particular, much of their work with Sarcoma has involved treating patients, or patients who are undergoing treatment.
Is Paul Meyers, MD currently recruiting for clinical trials?
No, Paul Meyers, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Paul Meyers, MD has studied deeply?
Yes, Paul Meyers, MD has studied treatments such as Irinotecan, Temozolomide, Seclidemstat.
What is the best way to schedule an appointment with Paul Meyers, MD?
Apply for one of the trials that Paul Meyers, MD is conducting.
What is the office address of Paul Meyers, MD?
The office of Paul Meyers, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.